B. Riley Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
B. Riley Wealth Management's BIIB Position: Q2 2022 in Review
B. Riley Wealth Management opened a new position in Biogen (BIIB) in Q2 2022: 681 shares worth $70.6K. The stake represents 0.08% of the portfolio and ranks #65 among its holdings. This is a return to the name: B. Riley Wealth Management previously reported a position in BIIB as recently as Q2 2015.
B. Riley Wealth Management first reported a position in BIIB in Q1 2014 and has held it in 7 quarters since. The position peaked at $245K in Q2 2014. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.
- B. Riley Wealth Management held 681 shares of Biogen worth $70.6K as of Q2 2022.
- Biogen was a new B. Riley Wealth Management position in Q2 2022.
- Biogen made up 0.08% of B. Riley Wealth Management's portfolio in Q2 2022, its #65 holding.
- B. Riley Wealth Management first reported a position in Biogen in Q1 2014 and has held it in 7 quarters since.
- B. Riley Wealth Management's Biogen position peaked at $245K in Q2 2014.
- 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.
Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.